Discontinued — last reported Q1 '20
Business Segments · Operating Lease, Impairment Loss
Covance Drug Development — Operating Lease, Impairment Loss
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2019
Last reportedQ1 2020
How to read this metric
An increase suggests operational restructuring, underutilized real estate, or a shift in the company's physical footprint strategy.
Detailed definition
The expense recognized when the carrying amount of an operating lease right-of-use asset is no longer recoverable. This...
Peer comparison
Commonly reported by large service-based firms undergoing real estate consolidation or footprint optimization.
Metric ID:
lh_segment_covance_drug_development_operating_lease_impairment_lossSimilar Metrics at Other Companies
Frequently Asked Questions
- What does covance drug development — operating lease, impairment loss mean?
- A charge taken when the value of leased property is reduced because the company no longer expects to derive full economic benefit from it.